1                  Limitations of the study are that, because we did not have access to secondary care prescribing informat

2                 Key limitations of our methodology are that we did not have an a priori protocol or statistical analysis

3                                                             We did not have annual county-level data on other important d

4 vice delivery model that was relatively intensive; and that we did not have comparable data from the 7 "standard-of-care"

5               The results of this study are limited in that we did not have contemporaneous controls for each interventio

6               The results of this study are limited in that we did not have contemporaneous controls for each interventio

7                       Limitations of our study include that we did not have data on ethnicity or body mass index, which m

8                    The main limitation of our study is that we did not have data on underlying cause of death; however, t

9 ssified in some cases due to inconsistent use of codes, and we did not have data to distinguish COVID-19 variants.

10 have very low confidence in all other effect estimates, and we did not have high confidence in any effect estimates.

11                                                          As we did not have high confidence in any outcomes, additional s

12                 However, a limitation of our study was that we did not have individual-level data on sun exposure, so we

13                                                             We did not have information on intravenous bisphosphonates.

14           Inherent to retrospective registry-based studies, we did not have information on potential confounders such as

15                                                             We did not have linked data on traveller demography or unbias

16 es concerning WHR, we excluded 3121 additional men for whom we did not have these measurements, assessed at the ninth yea